Steven M. Dubinett - Publications

Affiliations: 
Cellular & Molecular Pathology 049D University of California, Los Angeles, Los Angeles, CA 
Area:
Cell Biology, Molecular Biology, Pathology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle D, Spira AE, Elashoff DA, Wallace WD, ... ... Dubinett SM, et al. The immune contexture associates with the genomic landscape in lung adenomatous premalignancy. Cancer Research. PMID 31142513 DOI: 10.1158/0008-5472.CAN-19-0153  0.36
2019 Beane JE, Mazzilli SA, Campbell JD, Duclos G, Krysan K, Moy C, Perdomo C, Schaffer M, Liu G, Zhang S, Liu H, Vick J, Dhillon SS, Platero SJ, Dubinett SM, et al. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions. Nature Communications. 10: 1856. PMID 31015447 DOI: 10.1038/s41467-019-09834-2  0.36
2018 Pine PS, Lund SP, Parsons JR, Vang LK, Mahabal AA, Cinquini L, Kelly SC, Kincaid H, Crichton DJ, Spira A, Liu G, Gower AC, Pass HI, Goparaju C, Dubinett SM, et al. Summarizing performance for genome scale measurement of miRNA: reference samples and metrics. Bmc Genomics. 19: 180. PMID 29510677 DOI: 10.1186/s12864-018-4496-1  0.36
2018 Walser TC, Jing Z, Tran LM, Lin YQ, Yakobian N, Wang G, Krysan K, Zhu LX, Sharma S, Lee MH, Belperio JA, Ooi AT, Gomperts BN, Shay JW, Larsen JE, ... ... Dubinett SM, et al. Silencing the Snail-dependent RNA splice regulator ESRP1 drives malignant transformation of human pulmonary epithelial cells. Cancer Research. PMID 29431637 DOI: 10.1158/0008-5472.CAN-17-0315  0.36
2017 Pagano PC, Tran LM, Bendris N, O'Byrne S, Tse HT, Sharma S, Hoech JW, Park SJ, Liclican EL, Jing Z, Li R, Krysan K, Paul MK, Fontebasso Y, Larsen JE, ... ... Dubinett SM, et al. Identification of a human airway epithelial cell subpopulation with altered biophysical, molecular, and metastatic properties. Cancer Prevention Research (Philadelphia, Pa.). PMID 28754664 DOI: 10.1158/1940-6207.CAPR-16-0335  0.36
2017 Lee JMM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, ... ... Dubinett SM, et al. Phase I trial of intratumoral injection of CCL21 gene modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8+ T cell infiltration. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28468947 DOI: 10.1158/1078-0432.CCR-16-2821  0.36
2017 Kang S, Li Q, Chen Q, Zhou Y, Park S, Lee G, Grimes B, Krysan K, Yu M, Wang W, Alber F, Sun F, Dubinett SM, Li W, Zhou XJ. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biology. 18: 53. PMID 28335812 DOI: 10.1186/s13059-017-1191-5  0.36
2017 Momcilovic M, Bailey ST, Lee JT, Fishbein MC, Magyar C, Braas D, Graeber T, Jackson NJ, Czernin J, Emberley E, Gross M, Janes J, Mackinnon A, Pan A, Rodriguez M, ... ... Dubinett SM, et al. Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer. Cell Reports. 18: 601-610. PMID 28099841 DOI: 10.1016/j.celrep.2016.12.061  0.36
2015 Momcilovic M, McMickle R, Abt E, Seki A, Simko SA, Magyar C, Stout DB, Fishbein MC, Walser TC, Dubinett SM, Shackelford DB. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Research. 75: 4910-22. PMID 26574479 DOI: 10.1158/0008-5472.CAN-15-0797  0.36
2015 Reckamp KL, Koczywas M, Cristea MC, Dowell JE, Wang HJ, Gardner BK, Milne GL, Figlin RA, Fishbein MC, Elashoff RM, Dubinett SM. Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer. Cancer. PMID 26033830 DOI: 10.1002/cncr.29480  0.36
2014 Lee MH, Kachroo P, Pagano PC, Yanagawa J, Wang G, Walser TC, Krysan K, Sharma S, John MS, Dubinett SM, Lee JM. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. Journal of Cancer Science & Therapy. 6: 468-477. PMID 26523208 DOI: 10.4172/1948-5956.1000310  0.36
2014 Liclican EL, Walser TC, Hazra S, Krysan K, Park SJ, Pagano PC, Gardner BK, Larsen JE, Minna JD, Dubinett SM. Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. Cancer Prevention Research (Philadelphia, Pa.). 7: 845-55. PMID 24913817 DOI: 10.1158/1940-6207.CAPR-14-0063  0.36
2014 Lin Y, Luo J, Zhu WE, Srivastava M, Schaue D, Elashoff DA, Dubinett SM, Sharma S, Wu B, St John MA. A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 151: 447-53. PMID 24825873 DOI: 10.1177/0194599814533775  0.36
2014 Ooi AT, Gower AC, Zhang KX, Vick JL, Hong L, Nagao B, Wallace WD, Elashoff DA, Walser TC, Dubinett SM, Pellegrini M, Lenburg ME, Spira A, Gomperts BN. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 7: 487-95. PMID 24618292 DOI: 10.1158/1940-6207.CAPR-13-0372  0.36
2014 Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling. Cancer Investigation. 32: 136-43. PMID 24579933 DOI: 10.3109/07357907.2014.883528  0.36
2014 Krysan K, Kusko R, Grogan T, O'Hearn J, Reckamp KL, Walser TC, Garon EB, Lenburg ME, Sharma S, Spira AE, Elashoff D, Dubinett SM. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC. Molecular Cancer Research : McR. 12: 765-74. PMID 24469837 DOI: 10.1158/1541-7786.MCR-13-0377  0.36
2014 Garon EB, Christofk HR, Hosmer W, Britten CD, Bahng A, Crabtree MJ, Hong CS, Kamranpour N, Pitts S, Kabbinavar F, Patel C, von Euw E, Black A, Michelakis ED, Dubinett SM, et al. Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 140: 443-52. PMID 24442098 DOI: 10.1007/s00432-014-1583-9  0.36
2014 Grant JL, Fishbein MC, Hong LS, Krysan K, Minna JD, Shay JW, Walser TC, Dubinett SM. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis. Cancer Prevention Research (Philadelphia, Pa.). 7: 150-60. PMID 24253315 DOI: 10.1158/1940-6207.CAPR-13-0263  0.36
2013 Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research : Cr. 32: 97. PMID 24274066 DOI: 10.1186/1756-9966-32-97  0.36
2013 Perdomo C, Campbell JD, Gerrein J, Tellez CS, Garrison CB, Walser TC, Drizik E, Si H, Gower AC, Vick J, Anderlind C, Jackson GR, Mankus C, Schembri F, O'Hara C, ... ... Dubinett SM, et al. MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 110: 18946-51. PMID 24158479 DOI: 10.1073/pnas.1220319110  0.36
2013 Ofili EO, Fair A, Norris K, Verbalis JG, Poland R, Bernard G, Stephens DS, Dubinett SM, Imperato-McGinley J, Dottin RP, Pulley J, West A, Brown A, Mellman TA. Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium. Clinical and Translational Science. 6: 435-43. PMID 24119157 DOI: 10.1111/cts.12118  0.36
2013 Dubinett SM, Spira A. Challenge and opportunity of targeted lung cancer chemoprevention. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4169-71. PMID 24002497 DOI: 10.1200/JCO.2013.51.2400  0.36
2013 Krysan K, Cui X, Gardner BK, Reckamp KL, Wang X, Hong L, Walser TC, Rodriguez NL, Pagano PC, Garon EB, Brothers JF, Elashoff D, Lee JM, Spira AE, Sharma S, ... ... Dubinett SM, et al. Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. American Journal of Translational Research. 5: 481-96. PMID 23977408  0.36
2013 Ohashi K, Sequist LV, Arcila ME, Lovly CM, Chen X, Rudin CM, Moran T, Camidge DR, Vnencak-Jones CL, Berry L, Pan Y, Sasaki H, Engelman JA, Garon EB, Dubinett SM, et al. Characteristics of lung cancers harboring NRAS mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2584-91. PMID 23515407 DOI: 10.1158/1078-0432.CCR-12-3173  0.36
2013 Garon EB, Finn RS, Hamidi H, Dering J, Pitts S, Kamranpour N, Desai AJ, Hosmer W, Ide S, Avsar E, Jensen MR, Quadt C, Liu M, Dubinett SM, Slamon DJ. The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth. Molecular Cancer Therapeutics. 12: 890-900. PMID 23493311 DOI: 10.1158/1535-7163.MCT-12-0998  0.36
2013 Garon EB, Pietras RJ, Finn RS, Kamranpour N, Pitts S, Márquez-Garbán DC, Desai AJ, Dering J, Hosmer W, von Euw EM, Dubinett SM, Slamon DJ. Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 270-8. PMID 23399957 DOI: 10.1097/JTO.0b013e31827d525c  0.36
2013 Gomperts BN, Walser TC, Spira A, Dubinett SM. Enriching the molecular definition of the airway "field of cancerization:" establishing new paradigms for the patient at risk for lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 6: 4-7. PMID 23233734 DOI: 10.1158/1940-6207.CAPR-12-0470  0.36
2012 Dennis M, Wang G, Luo J, Lin Y, Dohadwala M, Abemayor E, Elashoff DA, Sharma S, Dubinett SM, St John MA. Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 147: 726-32. PMID 22568942 DOI: 10.1177/0194599812446407  0.36
2012 Hu D, Lau OD, Wang L, Wang G, Schaue D, Zhu L, Huang M, Lin Y, Dennis M, Abemayor E, Elashoff DA, Dubinett SM, McBride WH, Sharma S, Wu B, et al. A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model. Archives of Otolaryngology--Head & Neck Surgery. 138: 412-7. PMID 22508626 DOI: 10.1001/archoto.2012.20  0.36
2012 Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L1150-8. PMID 22345575 DOI: 10.1152/ajplung.00384.2010  0.36
2012 Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, Dubinett SM. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 5: 5-18. PMID 21922183 DOI: 10.1007/s12307-011-0089-0  0.36
2012 Mendelsohn AH, Lai CK, Shintaku IP, Fishbein MC, Brugman K, Elashoff DA, Abemayor E, Dubinett SM, St John MA. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. American Journal of Otolaryngology. 33: 6-13. PMID 21439681 DOI: 10.1016/j.amjoto.2010.11.018  0.36
2011 Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prevention Research (Philadelphia, Pa.). 4: 984-93. PMID 21733822 DOI: 10.1158/1940-6207.CAPR-11-0078  0.36
2011 Lee G, Gardner BK, Elashoff DA, Purcell CM, Sandha HS, Mao JT, Krysan K, Lee JM, Dubinett SM. Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients. American Journal of Translational Research. 3: 226-33. PMID 21654877  0.36
2011 Andersson A, Srivastava MK, Harris-White M, Huang M, Zhu L, Elashoff D, Strieter RM, Dubinett SM, Sharma S. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3660-72. PMID 21636553 DOI: 10.1158/1078-0432.CCR-10-3346  0.36
2011 Kar UK, Srivastava MK, Andersson A, Baratelli F, Huang M, Kickhoefer VA, Dubinett SM, Rome LH, Sharma S. Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth. Plos One. 6: e18758. PMID 21559281 DOI: 10.1371/journal.pone.0018758  0.36
2011 Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, Dubinett SM. Evolving concepts in lung carcinogenesis. Seminars in Respiratory and Critical Care Medicine. 32: 32-43. PMID 21500122 DOI: 10.1055/s-0031-1272867  0.36
2010 Hosmer WD, Dubinett SM, Garon EB. Novel drugs--miscellaneous category Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5. PMID 21102242  0.36
2010 Mendelsohn AH, Lai CK, Shintaku IP, Elashoff DA, Dubinett SM, Abemayor E, St John MA. Histopathologic findings of HPV and p16 positive HNSCC. The Laryngoscope. 120: 1788-94. PMID 20803740 DOI: 10.1002/lary.21044  0.36
2010 Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. American Journal of Translational Research. 2: 356-67. PMID 20733946  0.36
2010 Ooi AT, Mah V, Nickerson DW, Gilbert JL, Ha VL, Hegab AE, Horvath S, Alavi M, Maresh EL, Chia D, Gower AC, Lenburg ME, Spira A, Solis LM, Wistuba II, ... ... Dubinett SM, et al. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Research. 70: 6639-48. PMID 20710044 DOI: 10.1158/0008-5472.CAN-10-0455  0.36
2010 Dohadwala M, Wang G, Heinrich E, Luo J, Lau O, Shih H, Munaim Q, Lee G, Hong L, Lai C, Abemayor E, Fishbein MC, Elashoff DA, Dubinett SM, St John MA. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 142: 753-9. PMID 20416468 DOI: 10.1016/j.otohns.2010.01.034  0.36
2010 Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, et al. Cancer and inflammation: promise for biologic therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 335-51. PMID 20386472 DOI: 10.1097/CJI.0b013e3181d32e74  0.36
2010 Gomperts BN, Spira A, Elashoff DE, Dubinett SM. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection. Cancer Prevention Research (Philadelphia, Pa.). 3: 420-3. PMID 20332300 DOI: 10.1158/1940-6207.CAPR-10-0052  0.36
2009 Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, ... ... Dubinett SM, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6820-9. PMID 19887480 DOI: 10.1158/1078-0432.CCR-09-1558  0.36
2009 St John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, Zhu L, Lai C, Abemayor E, Fishbein M, Elashoff DA, ... ... Dubinett SM, et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6018-27. PMID 19789323 DOI: 10.1158/1078-0432.CCR-09-0011  0.36
2009 Limsukon A, Susanto I, Hoo GW, Dubinett SM, Batra RK. Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy. Chest. 136: 924-6. PMID 19736197 DOI: 10.1378/chest.08-2639  0.36
2009 Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. Bmc Cancer. 9: 213. PMID 19563666 DOI: 10.1186/1471-2407-9-213  0.36
2009 Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Current Opinion in Pulmonary Medicine. 15: 303-7. PMID 19417670 DOI: 10.1097/MCP.0b013e32832c975a  0.36
2009 Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP, Dubinett SM, Sondej MA, Loo JA, Rao JY. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics. 9: 757-67. PMID 19137550 DOI: 10.1002/pmic.200800019  0.36
2008 Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 117-24. PMID 18303430 DOI: 10.1097/JTO.0b013e3181622bef  0.36
2008 Krysan K, Lee JM, Dohadwala M, Gardner BK, Reckamp KL, Garon E, St John M, Sharma S, Dubinett SM. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 107-10. PMID 18303428 DOI: 10.1097/JTO.0b013e3181630ece  0.36
2008 Su H, Seimbille Y, Ferl GZ, Bodenstein C, Fueger B, Kim KJ, Hsu YT, Dubinett SM, Phelps ME, Czernin J, Weber WA. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1089-99. PMID 18239919 DOI: 10.1007/s00259-007-0636-6  0.36
2007 Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Review of Anticancer Therapy. 7: 1405-21. PMID 17944566 DOI: 10.1586/14737140.7.10.1405  0.36
2007 Liu M, Yang SC, Sharma S, Luo J, Cui X, Peebles KA, Huang M, Sato M, Ramirez RD, Shay JW, Minna JD, Dubinett SM. EGFR signaling is required for TGF-β1-mediated COX-2 induction in human bronchial epithelial cells American Journal of Respiratory Cell and Molecular Biology. 37: 578-588. PMID 17600311 DOI: 10.1165/rcmb.2007-0100OC  0.36
2007 Lee JM, Mao JT, Krysan K, Dubinett SM. Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncology (London, England). 3: 149-53. PMID 17381414 DOI: 10.2217/14796694.3.2.149  0.36
2006 Zeng G, Aldridge ME, Tian X, Seiler D, Zhang X, Jin Y, Rao J, Li W, Chen D, Langford MP, Duggan C, Belldegrun AS, Dubinett SM. Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. Journal of Immunology (Baltimore, Md. : 1950). 177: 3582-9. PMID 16951317  0.36
2006 Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, ... ... Dubinett SM, et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3661-97. PMID 16778094 DOI: 10.1158/1078-0432.CCR-06-1104  0.36
2006 Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3381-8. PMID 16740761 DOI: 10.1158/1078-0432.CCR-06-0112  0.36
2006 Krysan K, Reckamp KL, Sharma S, Dubinett SM. The potential and rationale for COX-2 inhibitors in lung cancer. Anti-Cancer Agents in Medicinal Chemistry. 6: 209-20. PMID 16712449  0.36
2006 Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Hong L, Lai C, Cameron RB, Gemmill RM, Drabkin HA, ... Dubinett SM, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Research. 66: 5338-45. PMID 16707460 DOI: 10.1158/0008-5472.CAN-05-3635  0.36
2005 Rodriguez PC, Hernandez CP, Quiceno D, Dubinett SM, Zabaleta J, Ochoa JB, Gilbert J, Ochoa AC. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. The Journal of Experimental Medicine. 202: 931-9. PMID 16186186 DOI: 10.1084/jem.20050715  0.36
2005 Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer. Clinical Lung Cancer. 7: 30-9. PMID 16098242 DOI: 10.3816/CLC.2005.n.019  0.36
2005 Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Research. 65: 6275-81. PMID 16024629 DOI: 10.1158/0008-5472.CAN-05-0216  0.36
2005 Heuzé-Vourc'h N, Liu M, Dalwadi H, Baratelli FE, Zhu L, Goodglick L, Põld M, Sharma S, Ramirez RD, Shay JW, Minna JD, Strieter RM, Dubinett SM. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression Biochemical and Biophysical Research Communications. 333: 470-475. PMID 15950941 DOI: 10.1016/j.bbrc.2005.05.122  0.36
2005 Baratelli F, Krysan K, Heuzé-Vourc'h N, Zhu L, Escuadro B, Sharma S, Reckamp K, Dohadwala M, Dubinett SM. PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells. Journal of Leukocyte Biology. 78: 555-64. PMID 15908458 DOI: 10.1189/jlb.1004569  0.36
2005 Gamradt SC, Feeley BT, Liu NQ, Roostaeian J, Lin YQ, Zhu LX, Sharma S, Dubinett SM, Lieberman JR. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone. Anticancer Research. 25: 107-15. PMID 15816526  0.36
2005 Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbins PF, Dubinett SM, deKernion JB, Belldegrun AS. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. International Journal of Cancer. Journal International Du Cancer. 114: 268-73. PMID 15540228 DOI: 10.1002/ijc.20716  0.36
2004 Baratelli FE, Heuzé-Vourc'h N, Krysan K, Dohadwala M, Riedl K, Sharma S, Dubinett SM. Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix Journal of Immunology. 173: 5458-5466. PMID 15494493  0.36
2004 Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer Cancer Research. 64: 6549-6555. PMID 15374967 DOI: 10.1158/0008-5472.CAN-04-1225  0.36
2004 Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. Multifaceted roles of cyclooxygenase-2 in lung cancer Drug Resistance Updates. 7: 169-184. PMID 15296859 DOI: 10.1016/j.drup.2004.04.003  0.36
2004 Dubinett SM, Elashoff D, Meyerson M. Assessing prognosis in non-small-cell lung cancer: Avenues to a more complete picture? Journal of Clinical Oncology. 22: 3209-3211. PMID 15249586 DOI: 10.1200/JCO.2004.05.931  0.36
2004 Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, Kuo BY, Gardner B, Batra RK, Strieter RM, Dubinett SM, Sharma S. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2891-901. PMID 15102698 DOI: 10.1158/1078-0432.CCR-03-0380  0.36
2004 Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Research. 64: 1853-60. PMID 14996749  0.36
Show low-probability matches.